Clinical Trials on Secondary Acute Myeloid Leukemia in New Zealand
Total 1036 results
-
Massachusetts General HospitalPatient-Centered Outcomes Research InstituteRecruitingHigh Risk Acute Myeloid Leukemia | Relapsed Adult AML | Primary Refractory Acute Myeloid LeukemiaUnited States
-
ChimerixTerminatedAcute Myeloid LeukemiaUnited States
-
Michael Pulsipher, MDSeattle Children's Hospital; Nationwide Children's HospitalEnrolling by invitation
-
National Cancer Institute (NCI)TerminatedRecurrent Adult Acute Myeloid Leukemia | Unspecified Adult Solid Tumor, Protocol Specific | Adult Acute Megakaryoblastic Leukemia (M7) | Adult Acute Minimally Differentiated Myeloid Leukemia (M0) | Adult Acute Monoblastic Leukemia (M5a) | Adult Acute Monocytic Leukemia (M5b) | Adult Acute Myeloblastic... and other conditionsUnited States
-
Fate TherapeuticsTerminatedAcute Myeloid Leukemia | Multiple Myeloma | Myeloma | AML, AdultUnited States
-
Y-mAbs TherapeuticsChildren's Oncology GroupTerminatedAML, ChildhoodUnited States
-
Novartis PharmaceuticalsCompletedAcute Myeloid LeukemiaUnited States, Canada
-
Cyclacel Pharmaceuticals, Inc.CompletedAcute Myeloid LeukemiaUnited States, Spain, France, Switzerland, Germany, Italy, Austria, Sweden, Hungary, Belgium, Poland, United Kingdom
-
Merus N.V.Active, not recruitingAcute Myeloid Leukemia | Acute Myelogenous LeukemiaUnited States, Italy, Netherlands, Belgium, France
-
Stemline Therapeutics, Inc.TerminatedAcute Myeloid LeukemiaUnited States
-
University of KentuckyNational Institutes of Health (NIH)CompletedAcute Myelogenous LeukemiaUnited States
-
Gilead SciencesTerminatedAcute Myeloid LeukemiaUnited States, Canada, Germany
-
Kronos BioTerminatedNucleophosmin 1-mutated Acute Myeloid LeukemiaIsrael, Spain, France, United States, Czechia, Hungary, Korea, Republic of, Germany, Italy, Poland, Brazil, Canada
-
Hoffmann-La RocheTerminatedAcute Myeloid LeukemiaSpain, United States, France, Australia, Italy
-
Race Oncology LtdAstex Pharmaceuticals, Inc.WithdrawnAcute Myeloid Leukemia | Chronic Myelomonocytic Leukemia | Recurrent Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Higher Risk Myelodysplastic SyndromeAustralia
-
National Cancer Institute (NCI)CompletedAcute Myeloid Leukemia | Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome | Therapy-Related Acute Myeloid LeukemiaUnited States
-
CelgeneActive, not recruitingLeukemia, Myeloid, AcuteUnited States, France, Italy, Korea, Republic of, Spain, United Kingdom, Australia, Canada, Germany, Netherlands, Portugal, Switzerland, Belgium, Sweden
-
Center for International Blood and Marrow Transplant...National Marrow Donor ProgramRecruitingAcute Myeloid Leukemia in RemissionUnited States
-
Novartis PharmaceuticalsNo longer availableAcute Myeloid Leukemia (AML) With | FLT3 Mutation, Internal Tandem Duplication (ITD) or Tyrosine Kinase Domain (TKD)United States
-
Astellas Pharma Global Development, Inc.National Heart, Lung, and Blood Institute (NHLBI); Blood and Marrow Transplant...CompletedAcute Myeloid LeukemiaUnited States, Japan, Korea, Republic of, Taiwan, Spain, Italy, United Kingdom, Australia, Belgium, Canada, Denmark, France, Germany, Greece, New Zealand, Poland
-
CelgeneActive, not recruitingLeukemia, Myeloid, AcuteUnited States, Australia, Brazil, Canada, Czechia, Finland, France, Germany, Italy, Korea, Republic of, Mexico, Portugal, Russian Federation, Spain, United Kingdom, Belgium, Taiwan, Austria, Ireland, Israel, Lithuania, Poland, Turkey
-
Malika KapadiaGlycoMimetics IncorporatedRecruitingAcute Myeloid Leukemia | Pediatric CancerUnited States
-
Syros PharmaceuticalsSuspendedAcute Promyelocytic LeukemiaUnited States
-
Eisai Inc.TerminatedPediatric Acute Myelogenous Leukemia (AML)United States, Canada, Australia
-
Astex Pharmaceuticals, Inc.CompletedAcute Myeloid LeukemiaUnited States, Canada, Belgium, Spain, Germany, Denmark, Korea, Republic of, Hungary, France, Japan, Italy, Poland, Sweden, Ukraine, United Kingdom
-
AbbVieGenentech, Inc.Active, not recruitingAcute Myeloid Leukemia (AML)United States, Australia, Austria, Belgium, Brazil, Canada, China, Croatia, Czechia, Denmark, Finland, France, Germany, Hungary, Israel, Italy, Japan, Korea, Republic of, Norway, Poland, Portugal, Puerto Rico, Russian Federation, South... and more
-
Astex Pharmaceuticals, Inc.TerminatedAcute Myeloid LeukemiaUnited States
-
Roswell Park Cancer InstituteCelgeneWithdrawnRecurrent Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | IDH2 Gene Mutation | Blasts Under 5 Percent of Peripheral Blood White Cells | Bone Marrow Blasts Decreased by 50 Percent or More Compared to Pretreatment LevelUnited States
-
Maxinovel Pty., Ltd.RecruitingAcute Myelogenous Leukemia (AML)Australia
-
Arog Pharmaceuticals, Inc.CompletedNewly Diagnosed AML With FLT3 Activating MutationsUnited States
-
Kartos Therapeutics, Inc.CompletedAcute Myeloid Leukemia | Cancer | Oncology | Advanced Malignancy | Oncology PatientsUnited States
-
Cyclacel Pharmaceuticals, Inc.CompletedAcute Myeloid LeukemiaUnited States
-
National Cancer Institute (NCI)Active, not recruitingAcute Myeloid Leukemia | Myeloid Neoplasm | Myeloid Sarcoma | Leukemia CutisUnited States, Canada, Australia, New Zealand, Puerto Rico
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedLeukemiaUnited States, Canada, Puerto Rico, Australia, Netherlands, New Zealand, Switzerland
-
National Cancer Institute (NCI)Active, not recruitingAcute Myeloid Leukemia | Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome | Recurrent Acute Myeloid Leukemia | Recurrent Myelodysplastic Syndrome | Refractory Acute Myeloid Leukemia | Refractory Myelodysplastic Syndrome | Acute Myeloid Leukemia Post Cytotoxic TherapyUnited States
-
AstraZenecaCompletedAcute Myeloid LeukemiaUnited States, Italy, United Kingdom, Romania, Japan, Australia, Germany, Spain, France
-
National Cancer Institute (NCI)Suspended
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedLeukemia | Anemia | Thrombocytopenia | NeutropeniaUnited States
-
Roswell Park Cancer InstituteGenzyme, a Sanofi CompanyTerminated
-
National Cancer Institute (NCI)Active, not recruitingAcute Myeloid LeukemiaUnited States, Canada
-
Kura Oncology, Inc.RecruitingNeoplasms by Histologic Type | Acute Myeloid Leukemia | Leukemia | Leukemia, Myeloid | Leukemia, Myeloid, Acute | AML | Acute Leukemia | Hematologic Malignancy | NPM1 Mutation | AML With Mutated NPM1 | KMT2Ar | MLL RearrangementUnited States
-
Astellas Pharma Global Development, Inc.Active, not recruitingAcute Myeloid Leukemia (AML) | Acute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) MutationUnited States, Japan, Taiwan, Spain, Australia, Belgium, Canada, France, Germany, Italy, Korea, Republic of, Poland, United Kingdom
-
Technische Universität DresdenPfizer; Novartis PharmaceuticalsRecruiting
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI); Southwest Oncology Group; Cancer and Leukemia...Completed
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)Completed
-
Viron Therapeutics IncVion PharmaceuticalsTerminatedAcute Myeloid Leukemia (AML) | Myelodysplastic Syndrome (MDS)United States
-
AbbVieGenentech, Inc.CompletedAML | Acute Myelogenous LeukemiaUnited States, Australia, Germany, Italy
-
PfizerCompletedLeukemia, Myeloid, AcuteUnited States, Spain, Canada, Israel, Korea, Republic of, Taiwan, France, Australia, Germany, Mexico, Japan, Sweden, China, Austria, Belgium, Czechia, Hungary, Italy, Poland, Romania, Russian Federation, United Kingdom
-
Dartmouth-Hitchcock Medical CenterNational Cancer Institute (NCI)CompletedLeukemiaUnited States
-
Wyeth is now a wholly owned subsidiary of PfizerCompletedAcute Myelogenous LeukemiaUnited States